Tryptophan Depletion Modulates Tryptophanyl-tRNA Synthetase-Mediated High-Affinity Tryptophan Uptake into Human Cells.
Biological Transport
/ drug effects
Buffers
Culture Media
HeLa Cells
Humans
Indoleamine-Pyrrole 2,3,-Dioxygenase
/ genetics
Interferon-gamma
/ pharmacology
Mutation, Missense
Point Mutation
Recombinant Proteins
/ metabolism
Transfer RNA Aminoacylation
Tryptophan
/ deficiency
Tryptophan Oxygenase
/ metabolism
Tryptophan-tRNA Ligase
/ pharmacology
Up-Regulation
amino acid transport
aminoacyl-tRNA synthetase
indoleamine 2,3-dioxygenase
interferon-γ
tryptophan 2,3-dioxygenase
tryptophan uptake
tryptophanyl-tRNA synthetase
Journal
Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097
Informations de publication
Date de publication:
27 11 2020
27 11 2020
Historique:
received:
22
09
2020
revised:
07
11
2020
accepted:
25
11
2020
entrez:
2
12
2020
pubmed:
3
12
2020
medline:
24
7
2021
Statut:
epublish
Résumé
The novel high-affinity tryptophan (Trp)-selective transport system is present at elevated levels in human interferon-γ (IFN-γ)-treated and indoleamine 2,3-dioxygenase 1 (IDO1)-expressing cells. High-affinity Trp uptake into cells results in extracellular Trp depletion and immune suppression. We have previously shown that both IDO1 and tryptophanyl-tRNA synthetase (TrpRS), whose expression levels are increased by IFN-γ, have a crucial function in high-affinity Trp uptake into human cells. Here, we aimed to elucidate the relationship between TrpRS and IDO1 in high-affinity Trp uptake. We demonstrated that overexpression of IDO1 in HeLa cells drastically enhances high-affinity Trp uptake upon addition of purified TrpRS protein to uptake assay buffer. We also clarified that high-affinity Trp uptake by Trp-starved cells is significantly enhanced by the addition of TrpRS protein to the assay buffer. Moreover, we showed that high-affinity Trp uptake is also markedly elevated by the addition of TrpRS protein to the assay buffer of cells overexpressing another Trp-metabolizing enzyme, tryptophan 2,3-dioxygenase (TDO2). Taken together, we conclude that Trp deficiency is crucial for high-affinity Trp uptake mediated by extracellular TrpRS.
Identifiants
pubmed: 33261077
pii: genes11121423
doi: 10.3390/genes11121423
pmc: PMC7760169
pii:
doi:
Substances chimiques
Buffers
0
Culture Media
0
IDO1 protein, human
0
Indoleamine-Pyrrole 2,3,-Dioxygenase
0
Recombinant Proteins
0
Interferon-gamma
82115-62-6
Tryptophan
8DUH1N11BX
Tryptophan Oxygenase
EC 1.13.11.11
Tryptophan-tRNA Ligase
EC 6.1.1.2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Oncotarget. 2015 Sep 8;6(26):21979-92
pubmed: 26110569
J Biol Chem. 2016 Aug 12;291(33):16927-35
pubmed: 27358398
Trends Mol Med. 2004 Jan;10(1):15-8
pubmed: 14720581
Annu Rev Biochem. 1987;56:125-58
pubmed: 3304131
Physiol Rev. 1990 Jan;70(1):43-77
pubmed: 2404290
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):173-7
pubmed: 11773626
Nat Microbiol. 2016 Oct 17;2:16191
pubmed: 27748732
Biochemistry. 2007 Oct 9;46(40):11291-8
pubmed: 17877375
J Biol Chem. 2003 Aug 8;278(32):29525-31
pubmed: 12766158
Nucleic Acids Res. 2004 Feb 02;32(2):719-27
pubmed: 14757836
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2497-502
pubmed: 22308364
Blood. 2004 Jun 15;103(12):4619-21
pubmed: 15001472
Arch Biochem Biophys. 2001 Aug 1;392(1):71-8
pubmed: 11469796
Immunol Rev. 2008 Apr;222:206-21
pubmed: 18364004
J Am Chem Soc. 2007 Dec 19;129(50):15690-701
pubmed: 18027945
Biochim Biophys Acta. 2015 Feb;1848(2):453-62
pubmed: 25450809
Nature. 2011 Oct 12;478(7368):192-4
pubmed: 21993754
Biochemistry. 2005 Jan 11;44(1):225-32
pubmed: 15628863
J Biol Chem. 2018 Jun 1;293(22):8428-8438
pubmed: 29666190
FASEB J. 1991 Aug;5(11):2516-22
pubmed: 1907934
J Immunol. 2000 Apr 1;164(7):3596-9
pubmed: 10725715
J Invest Dermatol. 1993 Jun;100(6):775-9
pubmed: 8496617
J Immunol. 2002 Apr 15;168(8):3771-6
pubmed: 11937528
Oncoimmunology. 2018 Sep 5;7(12):e1486353
pubmed: 30524887
Cytokine. 1995 Jan;7(1):70-7
pubmed: 7749068
Trends Biochem Sci. 2004 May;29(5):250-6
pubmed: 15130561
Nature. 2011 Oct 05;478(7368):197-203
pubmed: 21976023
Annu Rev Biochem. 1979;48:601-48
pubmed: 382994
Science. 2002 Sep 13;297(5588):1867-70
pubmed: 12228717
Trends Immunol. 2013 Mar;34(3):137-43
pubmed: 23103127
Nat Chem Biol. 2012 Apr 15;8(6):547-54
pubmed: 22504299
Electrophoresis. 1999 Apr-May;20(4-5):984-93
pubmed: 10344276
Sci Rep. 2016 Oct 20;6:35169
pubmed: 27762317
Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11520-4
pubmed: 1763065
Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11269-74
pubmed: 15277680
Cancer Res. 2016 Nov 1;76(21):6193-6204
pubmed: 27651314
Sci Rep. 2016 Apr 20;6:24750
pubmed: 27094087
Trends Endocrinol Metab. 2009 Nov;20(9):436-43
pubmed: 19800252
J Immunol. 2011 Aug 15;187(4):1617-25
pubmed: 21742973
Trends Biochem Sci. 1993 Jul;18(7):263-7
pubmed: 7692626
J Clin Invest. 2018 Nov 1;128(11):5163-5177
pubmed: 30153112
J Exp Med. 1999 May 3;189(9):1363-72
pubmed: 10224276
Nat Rev Immunol. 2004 Oct;4(10):762-74
pubmed: 15459668
Trends Pharmacol Sci. 2018 Mar;39(3):307-325
pubmed: 29254698
Nat Struct Mol Biol. 2010 Jan;17(1):57-61
pubmed: 20010843
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2611-6
pubmed: 16477023
J Biol Chem. 2008 Jan 25;283(4):2070-7
pubmed: 17999956
J Exp Med. 2002 Aug 19;196(4):447-57
pubmed: 12186837
Physiol Rev. 1998 Oct;78(4):969-1054
pubmed: 9790568
Biochem Soc Trans. 2008 Dec;36(Pt 6):1120-3
pubmed: 19021508
Science. 1998 Aug 21;281(5380):1191-3
pubmed: 9712583
Immunol Today. 1999 Oct;20(10):469-73
pubmed: 10500295
J Clin Invest. 2018 Nov 1;128(11):4767-4769
pubmed: 30320601
Eur J Immunol. 2009 Oct;39(10):2755-64
pubmed: 19637229
Proc Natl Acad Sci U S A. 1981 Jan;78(1):129-32
pubmed: 6165986
J Leukoc Biol. 2006 Dec;80(6):1320-7
pubmed: 16997853
J Biol Chem. 1991 Dec 25;266(36):24245-8
pubmed: 1761529
Nat Med. 2003 Oct;9(10):1269-74
pubmed: 14502282
Int J Cancer. 2002 Sep 10;101(2):151-5
pubmed: 12209992
Proteins. 2014 Nov;82(11):3210-6
pubmed: 25066423